Emerging markets make gains in medical technology innovation
Emerging markets such as China, India, and Brazil are “gaining ground” in medical technology innovation and may surpass developed countries in innovative healthcare delivery…
Web Exclusives
FDA advises women with breast impants
The U.S. Food and Drug Administration says women with breast implants may have a “very small, but increased risk” of developing anaplastic large cell…
FDA approves head lice treatment
The U.S. Food and Drug Administration has approved Natroba (spinosad) Topical Suspension 0.9% for the treatment of head lice in patients 4 years and…
Children with acute otitis media should receive antibiotics not observation
Recent studies published in the New England Journal of Medicine support treating children with acute otitis media with amoxicillin–clavulanate at the time of diagnosis…
FDA looks to improve medical device review process
The U.S. Food and Drug Administration plans to implement changes in 2011 designed to improve review of medical devices. Read more at http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm240418.htm.
National Priorities Partnership explores nursing’s contributions to healthcare transformation
Seeking to address major healthcare challenges, the National Priorities Partnership recognizes the many contributions nurses are making to advance its goals and transform health…
Metronidazole recall announced
The U.S. Food and Drug Administration (FDA) announced that Teva Pharmaceuticals, USA is voluntarily recalling Metronidazole Tablets USP, 250mg, lot 312566, expiration date 05/2012…
Color awareness: A must for patient assessment
Color “blindness” may help minimize social and economic disparities, but can impede accurate patient assessment. The author explains why nurses should practice color awareness…
More than half of liver transplant recipients develop metabolic syndrome
According to a study in January’s Liver Transplantation, more than half (52%) of liver transplant recipients develop metabolic syndrome. Read more at http://onlinelibrary.wiley.com/doi/10.1002/lt.22198/abstract.
Placebos without deception effective for IBS
An open-label study of 80 patients with irritable bowel syndrome (IBS) found that those who knew they were receiving a placebo still experienced improvements,…
NEJM interviews HHS Secretary on healthcare reform
The New England Journal of Medicine features an interview about healthcare reform with Health and Human Services’ Secretary Kathleen Sebelius. Read more at http://www.nejm.org/doi/full/10.1056/NEJMp1014722.
ECRI releases top 10 health technology hazards for 2011
ECRI Institute has released its Top 10 Lists of Health Technology Hazards for 2011: radiation therapy dose errors, alarm hazards, cross-contamination from flexible endoscopes,…
Emerging markets make gains in medical technology innovation
Emerging markets such as China, India, and Brazil are “gaining ground” in medical technology innovation and may surpass developed countries in innovative…
FDA advises women with breast impants
The U.S. Food and Drug Administration says women with breast implants may have a “very small, but increased risk” of developing anaplastic…
FDA approves head lice treatment
The U.S. Food and Drug Administration has approved Natroba (spinosad) Topical Suspension 0.9% for the treatment of head lice in patients 4…
Children with acute otitis media should receive antibiotics not observation
Recent studies published in the New England Journal of Medicine support treating children with acute otitis media with amoxicillin–clavulanate at the time…
FDA looks to improve medical device review process
The U.S. Food and Drug Administration plans to implement changes in 2011 designed to improve review of medical devices. Read more at…
National Priorities Partnership explores nursing’s contributions to healthcare transformation
Seeking to address major healthcare challenges, the National Priorities Partnership recognizes the many contributions nurses are making to advance its goals and…
Metronidazole recall announced
The U.S. Food and Drug Administration (FDA) announced that Teva Pharmaceuticals, USA is voluntarily recalling Metronidazole Tablets USP, 250mg, lot 312566, expiration…
Color awareness: A must for patient assessment
Color “blindness” may help minimize social and economic disparities, but can impede accurate patient assessment. The author explains why nurses should practice…
More than half of liver transplant recipients develop metabolic syndrome
According to a study in January’s Liver Transplantation, more than half (52%) of liver transplant recipients develop metabolic syndrome. Read more at…
Placebos without deception effective for IBS
An open-label study of 80 patients with irritable bowel syndrome (IBS) found that those who knew they were receiving a placebo still…
NEJM interviews HHS Secretary on healthcare reform
The New England Journal of Medicine features an interview about healthcare reform with Health and Human Services’ Secretary Kathleen Sebelius. Read more…
ECRI releases top 10 health technology hazards for 2011
ECRI Institute has released its Top 10 Lists of Health Technology Hazards for 2011: radiation therapy dose errors, alarm hazards, cross-contamination from…
Poll
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.